Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

catecholaminergic polymorphic ventricular tachycardia 5 News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A novel RYR2-A4510T variant has been identified, presenting both as autosomal dominant and autosomal recessive forms of catecholaminergic polymorphic ventricular tachycardia. This discovery enhances understanding of the genetic underpinnings of this arrhythmia.

A recent study evaluates missense variants in the RYR2 gene associated with catecholaminergic polymorphic ventricular tachycardia (CPVT). The research provides continuous Bayesian estimates of penetrance, enhancing understanding of genetic risk factors in this rare cardiac condition.

Not rare diseases news,news about your rare disease.

Earlier

A novel RYR2-A4510T variant has been identified, presenting both as autosomal dominant and autosomal recessive forms of catecholaminergic polymorphic ventricular tachycardia. This discovery enhances understanding of the genetic underpinnings of this arrhythmia.

A recent study evaluates missense variants in the RYR2 gene associated with catecholaminergic polymorphic ventricular tachycardia (CPVT). The research provides continuous Bayesian estimates of penetrance, enhancing understanding of genetic risk factors in this rare cardiac condition.

Not rare diseases news,
news about your rare disease.